Efficacy of immune checkpoint inhibitors in different types of melanoma

Author:

Rossi Ernesto1ORCID,Schinzari Giovanni12,Maiorano Brigida Anna2,Indellicati Giulia1,Di Stefani Alessandro3,Pagliara Monica Maria4,Fragomeni Simona Maria5,De Luca Erika Valentina6,Sammarco Maria Grazia4,Garganese Giorgia57,Galli Jacopo8,Blasi Maria Antonietta49,Paludetti Gaetano8,Scambia Giovanni510ORCID,Peris Ketty36,Tortora Giampaolo12

Affiliation:

1. Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

2. Medical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy

3. Dermatology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome – Italy

4. Ophtalmology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

5. Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

6. Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy

7. Ginecology and Breast Care Center, Mater Olbia Hospital, Olbia, Italy

8. Department of Head and Neck Surgery, Università Cattolica del Sacro Cuore, Rome, Italy

9. Ophtalmology, Università Cattolica del Sacro Cuore, Rome, Italy

10. Institute of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of mucosal melanoma;Holistic Integrative Oncology;2024-05-28

2. Targeted therapy in ophthalmic oncology: The current status;Asia-Pacific Journal of Ophthalmology;2024-03

3. Immunotherapy for lung cancer;Pathology - Research and Practice;2024-02

4. Editorial: Non-cutaneous melanoma: new therapeutic insights;Frontiers in Oncology;2024-01-17

5. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors;International Forum of Allergy & Rhinology;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3